Reducing Isotope Demand With an Innovative TRP Delivery Platform
Time: 12:45 pm
day: Conference Day One
Details:
- Common challenges of short-lived, rapidly clearing TRP. Strategies to overcome these challenges while maintaining product integrity and compliance with regulatory standards
- Evans Blue modification significantly improves pharmacokinetics of targeted peptide radiotherapeutics reducing required dose by >50%
- Lowering isotope use while maintaining efficacy and safety, improves costs, logistics and health economics, potentially expanding the market
